Also trades as: MYND.CN (CNQ) · $vol 0M
MYNDF OTC
MYND Life Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -41.3%
3Y: -55.0%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.7M
52W Range0.0081-0.0675
Volume7,920
Avg Volume6,688
Beta0.98
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWilfred A. Jefferies
SectorHealthcare
IndustryBiotechnology
IPO Date2021-09-22
Websitemyndsciences.com
Unit 150
Port Coquitlam, BC V3C 2B2
CA
Port Coquitlam, BC V3C 2B2
CA
+1 604 683 3995
About MYND Life Sciences Inc.
MYND Life Sciences Inc. operates as a neuro-pharmaceutical company, applying life science principles to develop innovative treatments for depressive conditions. The firm conducts scientific research and clinical trials in Canada and the United States, concentrating on therapeutic compounds that possess neuro-anti-inflammatory properties. A significant part of its research involves the in-depth study of psilocin and psilocybin extracts, along with their various analogs. The company's principal office is situated in Kelowna, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found